TNSN06293A1 - Ophthalmic solution comprising sodium carboxymethylcellulose and hydroxypropylmethylcellulose - Google Patents
Ophthalmic solution comprising sodium carboxymethylcellulose and hydroxypropylmethylcelluloseInfo
- Publication number
- TNSN06293A1 TNSN06293A1 TNP2006000293A TNSN06293A TNSN06293A1 TN SN06293 A1 TNSN06293 A1 TN SN06293A1 TN P2006000293 A TNP2006000293 A TN P2006000293A TN SN06293 A TNSN06293 A TN SN06293A TN SN06293 A1 TNSN06293 A1 TN SN06293A1
- Authority
- TN
- Tunisia
- Prior art keywords
- hydroxypropylmethylcellulose
- sodium carboxymethylcellulose
- ophthalmic solution
- hydrogen peroxide
- ocularly
- Prior art date
Links
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 title abstract 2
- 239000001768 carboxy methyl cellulose Substances 0.000 title abstract 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 title abstract 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 title abstract 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 title abstract 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 title abstract 2
- 229940054534 ophthalmic solution Drugs 0.000 title abstract 2
- 239000002997 ophthalmic solution Substances 0.000 title abstract 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 title abstract 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 title abstract 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract 6
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55388004P | 2004-03-17 | 2004-03-17 | |
| PCT/EP2005/002804 WO2005089715A1 (en) | 2004-03-17 | 2005-03-16 | Ophthalmic solution comprising sodium carboxymethylcellulose and hydroxypropylmethylcellulose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN06293A1 true TNSN06293A1 (en) | 2007-12-03 |
Family
ID=34962605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2006000293A TNSN06293A1 (en) | 2004-03-17 | 2006-09-15 | Ophthalmic solution comprising sodium carboxymethylcellulose and hydroxypropylmethylcellulose |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US20050244509A1 (enExample) |
| EP (1) | EP1732511A1 (enExample) |
| JP (1) | JP2007529458A (enExample) |
| KR (1) | KR20070005625A (enExample) |
| CN (1) | CN1933812A (enExample) |
| AU (1) | AU2005224012B2 (enExample) |
| BR (1) | BRPI0508858A (enExample) |
| CA (1) | CA2557795A1 (enExample) |
| EC (1) | ECSP066808A (enExample) |
| IL (1) | IL177725A0 (enExample) |
| MA (1) | MA28507B1 (enExample) |
| NO (1) | NO20064661L (enExample) |
| RU (1) | RU2006136092A (enExample) |
| TN (1) | TNSN06293A1 (enExample) |
| WO (1) | WO2005089715A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070048389A1 (en) * | 2005-08-26 | 2007-03-01 | Fu-Pao Tsao | Stabilized and preserved ketotifen ophthalmic compositions |
| US20070048388A1 (en) * | 2005-08-26 | 2007-03-01 | Fu-Pao Tsao | Stabilized and preserved ketotifen ophthalmic compositions |
| KR20140083056A (ko) | 2006-03-17 | 2014-07-03 | 존슨 앤드 존슨 비젼 케어, 인코포레이티드 | 산화에 불안정한 성분을 포함하는 안정화된 안과용 조성물 |
| US20070264226A1 (en) * | 2006-05-10 | 2007-11-15 | Karagoezian Hampar L | Synergistically enhanced disinfecting solutions |
| AU2013224663B2 (en) * | 2007-08-31 | 2015-01-15 | Alcon Inc. | Contact Lens Products |
| TWI551305B (zh) * | 2007-08-31 | 2016-10-01 | 諾華公司 | 相對黏稠封裝溶液之用途 |
| US20090239775A1 (en) * | 2008-03-19 | 2009-09-24 | Collins Gary L | Ophthalmic solutions displaying improved efficacy |
| TW201127423A (en) | 2009-12-17 | 2011-08-16 | Alcon Res Ltd | Ophthalmic solutions with improved disinfection profiles |
| US20150000936A1 (en) * | 2011-12-13 | 2015-01-01 | Schlumberger Technology Corporation | Energization of an element with a thermally expandable material |
| MY186090A (en) | 2015-12-03 | 2021-06-21 | Alcon Inc | Contact lens packaging solutions |
| US11185487B2 (en) | 2015-12-28 | 2021-11-30 | Johnson & Johnson Consumer Inc. | Hair growth composition and method |
| CN107041892B (zh) * | 2016-07-12 | 2021-02-26 | 合肥九研医药科技开发有限公司 | 羟丙基甲基纤维素在上消化道黏膜损伤护理上的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4880601A (en) * | 1985-09-27 | 1989-11-14 | Laboratoires, P.O.S. | Hydrogen peroxide disinfecting system for contact lenses |
| US5607698A (en) * | 1988-08-04 | 1997-03-04 | Ciba-Geigy Corporation | Method of preserving ophthalmic solution and compositions therefor |
| US5888493A (en) * | 1996-12-05 | 1999-03-30 | Sawaya; Assad S. | Ophthalmic aqueous gel formulation and related methods |
| DE60104872T2 (de) * | 2000-09-28 | 2005-09-01 | Novartis Ag | Stabilisierte ophthalmische wasserstoffperoxidlösung |
| AR038299A1 (es) * | 2002-01-18 | 2005-01-12 | Novartis Ag | Metodos para conservar soluciones oftalmicas y soluciones oftalmicas conservadas. |
-
2005
- 2005-03-11 US US11/078,209 patent/US20050244509A1/en not_active Abandoned
- 2005-03-16 EP EP05716123A patent/EP1732511A1/en not_active Withdrawn
- 2005-03-16 BR BRPI0508858-5A patent/BRPI0508858A/pt not_active IP Right Cessation
- 2005-03-16 RU RU2006136092/15A patent/RU2006136092A/ru unknown
- 2005-03-16 AU AU2005224012A patent/AU2005224012B2/en not_active Ceased
- 2005-03-16 CN CNA2005800084792A patent/CN1933812A/zh active Pending
- 2005-03-16 CA CA002557795A patent/CA2557795A1/en not_active Abandoned
- 2005-03-16 JP JP2007503283A patent/JP2007529458A/ja active Pending
- 2005-03-16 KR KR1020067018918A patent/KR20070005625A/ko not_active Withdrawn
- 2005-03-16 WO PCT/EP2005/002804 patent/WO2005089715A1/en not_active Ceased
-
2006
- 2006-08-28 IL IL177725A patent/IL177725A0/en unknown
- 2006-08-30 EC EC2006006808A patent/ECSP066808A/es unknown
- 2006-09-15 TN TNP2006000293A patent/TNSN06293A1/en unknown
- 2006-09-27 MA MA29348A patent/MA28507B1/fr unknown
- 2006-10-13 NO NO20064661A patent/NO20064661L/no not_active Application Discontinuation
-
2007
- 2007-12-20 US US11/961,034 patent/US20080096978A1/en not_active Abandoned
-
2010
- 2010-02-19 US US12/708,749 patent/US20100143493A1/en not_active Abandoned
-
2012
- 2012-05-07 US US13/465,225 patent/US20120220961A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20120220961A1 (en) | 2012-08-30 |
| AU2005224012A1 (en) | 2005-09-29 |
| JP2007529458A (ja) | 2007-10-25 |
| EP1732511A1 (en) | 2006-12-20 |
| ECSP066808A (es) | 2006-11-16 |
| CA2557795A1 (en) | 2005-09-29 |
| RU2006136092A (ru) | 2008-04-27 |
| MA28507B1 (fr) | 2007-04-03 |
| CN1933812A (zh) | 2007-03-21 |
| US20100143493A1 (en) | 2010-06-10 |
| US20050244509A1 (en) | 2005-11-03 |
| WO2005089715A1 (en) | 2005-09-29 |
| KR20070005625A (ko) | 2007-01-10 |
| NO20064661L (no) | 2006-12-14 |
| BRPI0508858A (pt) | 2007-08-28 |
| AU2005224012B2 (en) | 2009-07-02 |
| US20080096978A1 (en) | 2008-04-24 |
| IL177725A0 (en) | 2006-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201170703A1 (ru) | Производные адамантилбензамида | |
| MY150082A (en) | Trans-clomiphene for metabolic syndrome | |
| SG155961A1 (en) | Pyrazoles as 11-beta-hsd-1 | |
| SI1933809T1 (sl) | Sestavki za mazalno dajanje | |
| MX2010009336A (es) | Composiciones farmaceuticas acuosas que contienen complejos de borato-poliol. | |
| WO2007090192A3 (en) | Stable one-part aqueous tooth whitening composition | |
| CA2891921C (en) | Peroxide-stable oral care compositions | |
| TW200626558A (en) | Indazolone derivatives | |
| TW200740369A (en) | Pesticidally active compositions having enhanced activity | |
| TW200501965A (en) | Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle | |
| UA94065C2 (en) | Dihydropseudoerythromycin derivatives | |
| PT1377164E (pt) | A eritropoietina melhora a toxicidade induzida pela quimioterapia in vivo | |
| AU2001293851A1 (en) | Stabilized hydrogen peroxide solutions | |
| ECSP066808A (es) | Solución oftálmica que comprende carboximetilcelulosa de sodio e hidroxipropilmetilcelulosa | |
| TW200740429A (en) | Methods and dosage forms for reducing side effects of carbamate compounds | |
| AR057793A1 (es) | Derivado de colestanol, una formulacion liposomal y un complejo de inclusion de ciclodextrina que lo contienen y el uso del mismo en la produccion de un agente anticancer | |
| WO2008144185A3 (en) | Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods | |
| CY1111678T1 (el) | Σταθεροποιημενες και διατηρημενες οφθαλμικες ενωσεις κετοτιφενης | |
| MX2007006042A (es) | Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion, composiciones que las contienen y utilizacion. | |
| NO20065791L (no) | Asyklovir-formuleringer | |
| WO2008157744A3 (en) | Stabilizers for hydrophobic components in personal care compositions | |
| MX2007013449A (es) | Composicion cosmetica para despigmentacion o aclaracion que comprende al menos una oxazolina como un ingrediente activo. | |
| NZ583971A (en) | Foam stabilizer for a sterilization composition | |
| MX2008006476A (es) | Composiciones de lipopeptidos. | |
| WO2008002582A3 (en) | Ultraviolet absorbing ophthalmic compositions |